Literature DB >> 9765070

Reduction of cisplatin toxicity in cultured renal tubular cells by the bioflavonoid quercetin.

M K Kuhlmann1, E Horsch, G Burkhardt, M Wagner, H Köhler.   

Abstract

Quercetin (QC), a polyphenolic compound widely distributed in fruits and vegetables has recently gained interest due to its cisplatin (CP) sensitizing properties in cancer cells. It is currently unknown, whether quercetin also increases the susceptibility of the kidneys to cisplatin toxicity. We studied the effects of various bioflavonoids on CP toxicity in an in vitro model of cultured tubular epithelial cells (LLC-PK1). Viability of LLC-PK1 cells, as assessed by lactate dehydrogenase (LDH) release and MTT-test, was affected by CP (100-400 microM) in a time and dose dependent fashion. Pretreatment of cells with QC for 3 h significantly reduced the extent of cell damage. The protective activity of QC was concentration dependent, starting at 10-25 microM and reaching a plateau between 50 and 100 microM. Other bioflavonoids (catechin, silibinin, rutin) did not diminish cellular injury, even at higher concentrations (100-500 microM). Quercetin itself showed some intrinsic cytotoxicity at concentrations exceeding 75 microM. Our data indicate that quercetin reduces cisplatin toxicity in cultured tubular epithelial cells. The exact mechanism of protection is unclear, though scavenging of free oxygen radicals may play an important role.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765070     DOI: 10.1007/s002040050539

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  14 in total

1.  Alleviation of cisplatin-induced acute kidney injury using phytochemical polyphenols is accompanied by reduced accumulation of indoxyl sulfate in rats.

Authors:  Masahiro Kusumoto; Hiroki Kamobayashi; Daisuke Sato; Megumi Komori; Misato Yoshimura; Akinobu Hamada; Yukimasa Kohda; Kimio Tomita; Hideyuki Saito
Journal:  Clin Exp Nephrol       Date:  2011-08-23       Impact factor: 2.801

2.  PLGA nanoparticles loaded with etoposide and quercetin dihydrate individually: in vitro cell line study to ensure advantage of combination therapy.

Authors:  Smita Pimple; Arehalli S Manjappa; Mukesh Ukawala; R S R Murthy
Journal:  Cancer Nanotechnol       Date:  2012-05-09

3.  Quercetin Remodels the Tumor Microenvironment To Improve the Permeation, Retention, and Antitumor Effects of Nanoparticles.

Authors:  Kaili Hu; Lei Miao; Tyler J Goodwin; Jun Li; Qi Liu; Leaf Huang
Journal:  ACS Nano       Date:  2017-04-21       Impact factor: 15.881

Review 4.  The role of toxicoproteomics in assessing organ specific toxicity.

Authors:  B Alex Merrick; Frank A Witzmann
Journal:  EXS       Date:  2009

5.  Protective effects of amifostine, curcumin, and melatonin against cisplatin-induced acute kidney injury.

Authors:  Filiz Mercantepe; Tolga Mercantepe; Atilla Topcu; Adnan Yılmaz; Levent Tumkaya
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-06-02       Impact factor: 3.000

6.  Quercetin-induced inhibition and synergistic activity with cisplatin - a chemotherapeutic strategy for nasopharyngeal carcinoma cells.

Authors:  Maelinda Daker; Munirah Ahmad; Alan Sb Khoo
Journal:  Cancer Cell Int       Date:  2012-07-18       Impact factor: 5.722

7.  Quercetin protects primary human osteoblasts exposed to cigarette smoke through activation of the antioxidative enzymes HO-1 and SOD-1.

Authors:  Karl F Braun; Sabrina Ehnert; Thomas Freude; José T Egaña; Thilo L Schenck; Arne Buchholz; Andreas Schmitt; Sebastian Siebenlist; Lilianna Schyschka; Markus Neumaier; Ulrich Stöckle; Andreas K Nussler
Journal:  ScientificWorldJournal       Date:  2011-11-30

8.  Synergistic Effect of Subtoxic-dose Cisplatin and TRAIL to Mediate Apoptosis by Down-regulating Decoy Receptor 2 and Up-regulating Caspase-8, Caspase-9 and Bax Expression on NCI-H460 and A549 Cells.

Authors:  Xiaoyan Zhang; Jing Zhao; Wenyan Zhu; Hongfeng Gou; Dan Cao; Yu Yang; Ying Huang; Cheng Yi
Journal:  Iran J Basic Med Sci       Date:  2013-05       Impact factor: 2.699

9.  The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy.

Authors:  Maria Isabel Azevedo; Anamaria Falcão Pereira; Ricardo Braz Nogueira; Flávio Esmeraldo Rolim; Gerly A C Brito; Deysi Viviana T Wong; Roberto C P Lima-Júnior; Ronaldo de Albuquerque Ribeiro; Mariana Lima Vale
Journal:  Mol Pain       Date:  2013-10-23       Impact factor: 3.395

10.  Chemotherapy and dietary phytochemical agents.

Authors:  Katrin Sak
Journal:  Chemother Res Pract       Date:  2012-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.